Skip to main content
. Author manuscript; available in PMC: 2017 Feb 18.
Published in final edited form as: J Womens Health (Larchmt). 2012 Jul 20;21(8):801–808. doi: 10.1089/jwh.2012.3796

Table 2.

Knowledge, Attitudes, and Perceived Barriers Toward Alternative Technologies for Cervical Cancer Prevention, Bolivia, 2011–2012 (n = 42)

Item n (%)
Knowledge
 HPV infection and HPV vaccinea
  HPV increases risk for vaginal cancer 13 (31.0)
  Most women with HPV infection are asymptomatic 39 (95.1)
  HPV infection cause most cases of cervical cancer 37 (92.5)
  HPV vaccine protects against 2 types of HPV 39 (92.9)
  HPV vaccine may protect against vulvar cancer 18 (42.9)
  HPV vaccine may help prevent penile cancer 10 (24.4)
 Perceived effectiveness of screening testsb
  HPV 14 (46.7)
  VIA 23 (57.5)
  Cytology 12 (30.8)
 Familiar with the advantages of the self-collected HPV test 7 (17.1)
Attitudes on VIA and cryotherapy
 Acceptability
  Think patients would accept VIA and cryotherapyc 41 (100.0)
  Think their colleagues would accept VIA and cryotherapy 29 (70.7)
  Think VIA should replace the Pap test 25 (61.0)
  Think VIA and cryotherapy would have an impact on other health services 30 (75.0)
  Think performing VIA and cryotherapy in a single visit is not feasible in their specific health facility 17 (41.5)
 3 main challenges to implement a single visit screen-and-treat approachd
  Lack of equipment 14 (87.5)
  Lack of capacity 8 (50.0)
  Few health professionals in hospital/health center 4 (25.0)
Attitudes on HPV testing and HPV vaccine
 Would recommend the HPV vaccine to female patients 38 (92.7)
 Think incorporation of HPV testing is feasible within 5 years 8 (42.1)
Perceived barriers for early detection of cervical cancere
 General barriers
  Cultural 31 (75.6)
  Political 2 (5.0)
  Economic 3 (7.5)
  Organizational 4 (10.0)
 Specific barriersf
  The taboo about Pap testing among women 30 (71.4)
  Lack of educational campaigns and infrastructure 22 (52.4)
  Lack of dissemination of screening guidelines 17 (40.5)
  Lack of knowledge about cervical cancer 16 (38.1)
  Lack of priority given to women’s health 13 (31.0)
  Lack of infrastructure and organization of the Bolivian healthcare system 12 (28.6)
  The belief that cancer cannot be prevented 9 (21.4)
  The stigma related to cervical cancer for being a sexually transmitted illness 6 (14.3)
 Level of awareness among patients about getting screened for cervical cancer
  High 2 (4.8)
  Moderate 15 (35.7)
  Low 22 (52.4)
  None 3 (7.1)

All items were asked at pretest except for those related to attitudes on specific procedures.

a

No. of correct responses.

b

No. of participants who reported that the test is very effective.

c

n = 41.

d

Participants were instructed to check all that apply. Only the most cited categories are presented.

e

Participants were given 4 barriers and asked to list them according to their level of importance in preventing early detection of cervical cancer.

f

Participants were asked to select 3 of the 8 barriers listed.

HPV, human papillomavirus; VIA, visual inspection with acetic acid.